- cafead   Sep 03, 2019 at 11:32: PM
via Micro-cap biotech Aridis Pharmaceuticals $ARDS got hammered this morning as investigators revealed that one of its clinical-stage drugs failed a mid-stage study, triggering safety fears and forcing the company to dump the program.
article source
article source